Monday, November 28, 2016

BRIEF-Global Blood Therapeutics to initiate mid-stage trial for the treatment of idiopathic pulmonary fibrosis

* Global Blood Therapeutics announces initiation of phase 2a

trial of GBT440 in idiopathic pulmonary fibrosis (IPF)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)